Recently, Zhaoyan Medicine has taken a key step in the process of automation and intelligence, and the digital pathology assisted analysis system developed by the two sides has been widely recognized in practical applications. On the basis of completing    the digital transformation, Zhaoyan continues to deepen the field of AI, introduces a full range of AI-assisted diagnosis technology, broadens the application scenarios of AI technology in the field of CRO, and can better provide customers with intelligent    solutions and improve research and development efficiency. In the future, Zhaoyan will continue to deepen its integration with AI technology and continue to explore more possibilities of combining with drug research and development.

About "Digital Pathology Assisted Analysis System"

The digital pathology assisted analysis system effectively combines Zhaoyan's rich experience and huge background data in the field of non-clinical pathology with the advantage algorithm of AI intelligence in AI, and realizes the application of AI-assisted    diagnosis in multiple organ categories of experimental animal species, digital slice intelligent quality control, AI model autonomous training and other scenarios. The application of AI-assisted diagnosis makes pathological diagnosis faster and more    accurate. After using AI to analyze data, the human-effectiveness ratio can be improved by 50 to 100 times in some links, and the accuracy, consistency and efficiency are far greater than that of humans.

Recently, Zhaoyan Medicine has taken a key step in the process of automation and intelligence, and the digital pathology assisted analysis system developed by the two sides has been widely recognized in practical applications. On the basis of completing    the digital transformation, Zhaoyan continues to deepen the field of AI, introduces a full range of AI-assisted diagnosis technology, broadens the application scenarios of AI technology in the field of CRO, and can better provide customers with intelligent    solutions and improve research and development efficiency. In the future, Zhaoyan will continue to deepen its integration with AI technology and continue to explore more possibilities of combining with drug research and development.